<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.openbell.ai/</loc>
    <lastmod>2026-10-02T13:52:53.955Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/support</loc>
    <lastmod>2026-10-02T13:52:53.955Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/privacy</loc>
    <lastmod>2026-10-02T13:52:53.955Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/terms</loc>
    <lastmod>2026-10-02T13:52:53.955Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/feed.json</loc>
    <lastmod>2026-10-02T13:52:53.955Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NVDA:1790949152682</loc>
    <lastmod>2026-10-02T13:52:32.682Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nvidia&amp;#39;s &amp;#39;Very Undemanding Valuation&amp;#39; Helps Win Back Top Chip Pick From Leading Analyst</image:title>
      <image:caption>Nvidia Corp. has been reinstated as Morgan Stanley&#39;s top semiconductor stock, attributed to its attractive valuation and strong earnings expectations in the AI infrastructure market. The company recently announced a $150 billion stock buyback, which is expected to reduce its share count by approximately 4.2% over the next 16 months, potentially boosting adjusted EPS by 1.6%. Year-to-date, Nvidia&#39;s stock has risen about 26.62%, closing at $236.53, reflecting strong market performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/STX:1790949116197</loc>
    <lastmod>2026-10-02T13:51:56.197Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Why Is Seagate Technology Stock Sinking Friday?</image:title>
      <image:caption>Seagate Technology Holdings PLC (NASDAQ: STX) experienced a stock decline of over 13% on Friday, despite a positive broader market, following Toshiba&#39;s announcement to double its hard disk drive production capacity by fiscal 2027. This move raised concerns about potential pricing pressures in the HDD market, although demand for nearline HDDs remains strong due to AI data center needs. Seagate&#39;s upcoming earnings report is anticipated on October 27, 2026, with analysts projecting EPS of $5.80 and revenue of $3.75 billion, reflecting significant growth from the previous year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ISO:1790948991516</loc>
    <lastmod>2026-10-02T13:49:51.516Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ISO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Initiates Coverage On IsoEnergy with Outperform Rating, Announces Price Target of C$25</image:title>
      <image:caption>RBC Capital analyst Andrew D. Wong has initiated coverage on IsoEnergy (TSX: ISO) with an Outperform rating. The firm has set a price target of C$25 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/WOLF:1790948932529</loc>
    <lastmod>2026-10-02T13:48:52.529Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/WolfspeedStuttgart--Germany---09-20-2022.jpg?width=250&amp;height=187</image:loc>
      <image:title>Wolfspeed&amp;#39;s Busy Week: A New Substrate Launch, a Sector-Wide Rally</image:title>
      <image:caption>Wolfspeed Inc. (NYSE: WOLF) launched its new Premium 200mm n-type silicon carbide substrate on September 27, aimed at improving yield and wafer stability. The company is benefiting from a broader semiconductor rally following Micron&#39;s strong fiscal fourth-quarter results, which exceeded earnings expectations and lifted semiconductor stocks, including a more than 10% increase in Wolfspeed&#39;s stock on October 1. As of the latest update, Wolfspeed shares are trading 3.63% higher at $32.30.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/POAS:1790948806942</loc>
    <lastmod>2026-10-02T13:46:46.942Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/POAS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Phaos Technology Holdings shares are trading lower after the company announced a 1-for-15 reverse stock split.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SEIC:1790948788756</loc>
    <lastmod>2026-10-02T13:46:28.756Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SEIC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wells Fargo Initiates Coverage On SEI Investments with Overweight Rating, Announces Price Target of $129</image:title>
      <image:caption>Wells Fargo analyst Daniel Welden has initiated coverage on SEI Investments (NASDAQ: SEIC) with an Overweight rating. The firm has set a price target of $129 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ENTG:1790948773270</loc>
    <lastmod>2026-10-02T13:46:13.270Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/Rocket-Companies-Logo-Displayed-On-A-Sma.jpg?width=250&amp;height=187</image:loc>
      <image:title>10 Stocks Rally as Rate Hike Bets Collapse on Weak September Jobs</image:title>
      <image:caption>The U.S. economy added only 29,000 jobs in September, significantly below the expected 90,000, leading to a rise in stocks as rate hike bets diminished. The unemployment rate increased to 4.2%, and wage growth was 3%, below the anticipated 3.2%. Following the report, the chance of a 25-basis-point rate hike this month dropped from 23% to 13%. Among the stocks that rallied, Entegris Inc. saw a premarket gain of 4.39%, while Rocket Companies Inc. rose by 3.54%.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/WDC:1790948633739</loc>
    <lastmod>2026-10-02T13:43:53.739Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WDC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Toshiba Wants to Double HDD Supply — Western Digital, Seagate Investors Don’t Like It</image:title>
      <image:caption>Toshiba plans to double its hard disk drive (HDD) supply by fiscal 2027, investing approximately 60 billion yen ($380 million) to expand facilities in the Philippines, which has caused stock declines for Western Digital and Seagate Technology. Western Digital&#39;s stock fell 7.95% and Seagate&#39;s by 11.22% amid concerns that increased capacity could pressure pricing in the HDD market. Despite this, S&amp;P Global recently raised Western Digital&#39;s outlook to positive, citing a projected revenue growth of 44% in fiscal 2027 and free cash flow expectations of $5 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/POAS:1790948264822</loc>
    <lastmod>2026-10-02T13:37:44.822Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/POAS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Reported Earlier, Phaos Technology Announces 1-For-15 Reverse Stock Split, Effective October 12</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ON:1790948225679</loc>
    <lastmod>2026-10-02T13:37:05.679Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/ON-Semiconductor-Corp.jpg?width=250&amp;height=187</image:loc>
      <image:title>ON Semiconductor Shares Jump After Revised Synaptics Merger Deal</image:title>
      <image:caption>ON Semiconductor Corp (NASDAQ: ON) shares rose over 7% in premarket trading following a revised merger agreement with Synaptics Incorporated (NASDAQ: SYNA), which will see ON Semiconductor acquire Synaptics for $123 per share, valuing the deal at approximately $5.7 billion. The transaction will be funded through cash on hand and committed financing, with the U.S. Federal Trade Commission already approving the merger. ON Semiconductor anticipates immediate adjusted EPS accretion post-closing and has identified additional value-creation opportunities beyond the previously announced $200 million in annual run-rate synergies.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LPLA:1790948222543</loc>
    <lastmod>2026-10-02T13:37:02.543Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LPLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wells Fargo Initiates Coverage On LPL Finl Hldgs with Overweight Rating, Announces Price Target of $362</image:title>
      <image:caption>Wells Fargo analyst Daniel Welden has initiated coverage on LPL Financial Holdings (NASDAQ: LPLA) with an Overweight rating. The firm has set a price target of $362 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BTDR:1790948103140</loc>
    <lastmod>2026-10-02T13:35:03.140Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/Woman-Crypto-Trader-Investor-Broker-Usin.jpg?width=250&amp;height=187</image:loc>
      <image:title>Bitdeer Stock Jumps as H.C. Wainwright Highlights $1.7 Billion AI Cloud Revenue Commitments</image:title>
      <image:caption>Bitdeer Technologies Group Inc. (NASDAQ: BTDR) shares rose 6.95% to $11.39 following H.C. Wainwright&#39;s reiteration of a Buy rating and a $25 price target, driven by new AI Cloud offtake commitments. These commitments cover over 70% of Bitdeer&#39;s 21.7-megawatt facility in Malaysia and are expected to generate more than $1.7 billion in revenue over five years, equating to approximately $340 million in annual recurring revenue. This announcement more than doubles the total contracted revenue for the AI Cloud business.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/IBKR:1790948037746</loc>
    <lastmod>2026-10-02T13:33:57.746Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IBKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wells Fargo Initiates Coverage On Interactive Brokers Group with Overweight Rating, Announces Price Target of $102</image:title>
      <image:caption>Wells Fargo analyst Daniel Welden has initiated coverage on Interactive Brokers Group (NASDAQ: IBKR) with an Overweight rating. The firm has set a price target of $102 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CLYM:1790947988572</loc>
    <lastmod>2026-10-02T13:33:08.572Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CLYM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Climb Bio To Present New Data For Its CLYM116, Budoprutug Programs Across Three Immune-Mediated Kidney Diseases At American Society Of Nephrology Kidney Week 2026</image:title>
      <image:caption>Climb Bio, Inc. (NASDAQ: CLYM) will present new clinical data for its CLYM116 and budoprutug programs targeting three immune-mediated kidney diseases at the American Society of Nephrology Kidney Week 2026, scheduled for October 21-25, 2026, in Denver, Colorado.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LTC:1790947978724</loc>
    <lastmod>2026-10-02T13:32:58.724Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LTC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Outperform on LTC Properties, Raises Price Target to $52</image:title>
      <image:caption>RBC Capital analyst Michael Carroll has maintained an Outperform rating on LTC Properties (NYSE:LTC) and raised the price target from $45 to $52. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MERC:1790947869657</loc>
    <lastmod>2026-10-02T13:31:09.657Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MERC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Mercer International Board And Ad Hoc Group Intended To Address Its Upcoming Debt Maturities; Company Is Optimistic That It Will Be Able To Announce Transaction In Near Term; Skipped ~$25.8M Interest Payment Due October 1 On Its 2028 Notes, Opted To Utilize 30-Day Grace Period</image:title>
      <image:caption>Mercer International Inc. is in advanced discussions with an ad hoc group of holders of its 12.875% Senior Notes due 2028 and 5.125% Senior Notes due 2029 to finalize a comprehensive recapitalization transaction aimed at addressing upcoming debt maturities and enhancing liquidity. The company has opted to skip a $25.8 million interest payment due on October 1, 2026, utilizing a 30-day grace period without triggering a default. Despite these financial maneuvers, Mercer continues its operations normally and maintains its commitments to customers and suppliers.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/INTU:1790947838774</loc>
    <lastmod>2026-10-02T13:30:38.774Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INTU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Reiterates Outperform on Intuit, Maintains $385 Price Target</image:title>
      <image:caption>RBC Capital analyst Rishi Jaluria has reiterated an &#39;Outperform&#39; rating on Intuit (NASDAQ: INTU) and has maintained a price target of $385 for the stock. No additional financial figures or strategic changes were mentioned in the article.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ACN:1790947750250</loc>
    <lastmod>2026-10-02T13:29:10.250Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Outperform on Accenture, Raises Price Target to $240</image:title>
      <image:caption>RBC Capital analyst David Paige has maintained an Outperform rating on Accenture (NYSE: ACN) and raised the price target from $175 to $240. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AZN:1790947742407</loc>
    <lastmod>2026-10-02T13:29:02.407Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership</image:title>
      <image:caption>AstraZeneca PLC and Daiichi Sankyo Co., Ltd. have entered a clinical collaboration with Summit Therapeutics Inc. to test a new cancer-drug combination, starting with a Phase 3 trial in first-line triple-negative breast cancer. AstraZeneca will invest $2 billion in Summit to support the development of ivonescimab in combination with antibody-drug conjugates. Under the agreement, all three companies will share trial expenses while retaining development and commercial rights to their respective products.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MU:1790947736559</loc>
    <lastmod>2026-10-02T13:28:56.559Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/Image-Of-A-Micron-High-Bandwidth-Memory-.jpg?width=250&amp;height=187</image:loc>
      <image:title>EXCLUSIVE: Micron’s NAND Revenue Surged 526%: Why AI Data Centers Need So Much Storage</image:title>
      <image:caption>Micron Technology Inc. (NASDAQ: MU) reported a 526% year-over-year surge in NAND revenue, reaching a record $14.1 billion in its fiscal fourth quarter, driven by increased storage demands from AI data centers. The company&#39;s data-center SSD revenue approached $10 billion, more than ten times the previous year&#39;s level, comprising over two-thirds of its total NAND revenue. Additionally, NAND prices rose approximately 30% sequentially, as cloud providers accelerated SSD orders in anticipation of tighter supply and higher costs.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AZN:1790947716291</loc>
    <lastmod>2026-10-02T13:28:36.291Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/doctor--patient--breast-cancer.jpg?width=250&amp;height=187</image:loc>
      <image:title>AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership</image:title>
      <image:caption>AstraZeneca PLC and Daiichi Sankyo Co., Ltd. have entered a clinical collaboration with Summit Therapeutics Inc. to test a new cancer-drug combination, starting with a Phase 3 trial in first-line triple-negative breast cancer. AstraZeneca will invest $2 billion in Summit to support the development of ivonescimab in combination with antibody-drug conjugates. Each company will share trial expenses while retaining rights to their respective products. AstraZeneca shares rose 0.59% to $158.63 in premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FPS:1790947711354</loc>
    <lastmod>2026-10-02T13:28:31.354Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Forgent Power Solutions shares are trading higher after Bernstein initiated coverage on the stock with an Outperform rating and announced a $48 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/STZ:1790947592409</loc>
    <lastmod>2026-10-02T13:26:32.409Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Reiterates Outperform on Constellation Brands, Maintains $185 Price Target</image:title>
      <image:caption>RBC Capital analyst Nik Modi has reiterated an &#39;Outperform&#39; rating on Constellation Brands (NYSE: STZ) and has maintained a price target of $185 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NOC:1790947455049</loc>
    <lastmod>2026-10-02T13:24:15.049Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NOC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Downgrades Northrop Grumman to Sector Perform, Lowers Price Target to $525</image:title>
      <image:caption>RBC Capital analyst Ken Herbert has downgraded Northrop Grumman (NYSE: NOC) from Outperform to Sector Perform. The price target for the stock has been reduced from $640 to $525.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SAIQ:1790947446045</loc>
    <lastmod>2026-10-02T13:24:06.045Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SAIQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>WISeSat.Space Shares Open Trading On October 2 Following Merger With Columbus Acquisition Corp</image:title>
      <image:caption>WISeSat.Space Holdings Corp. (NASDAQ: SAIQ) completed its merger with Columbus Acquisition Corp on October 1, 2026, which was approved by CAC’s shareholders on September 30, 2026. The company&#39;s shares began trading on Nasdaq on October 2, 2026, marking a significant step in its mission to enhance secure satellite communications and IoT connectivity. WISeSat.Space aims to leverage cybersecurity and digital identity expertise to expand its space infrastructure and support secure communications for connected devices.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/STEP:1790947402680</loc>
    <lastmod>2026-10-02T13:23:22.680Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STEP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wells Fargo Initiates Coverage On StepStone Group with Overweight Rating, Announces Price Target of $55</image:title>
      <image:caption>Wells Fargo analyst Daniel Welden has initiated coverage on StepStone Group (NASDAQ: STEP) with an Overweight rating. The firm has set a price target of $55 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VSNT:1790947292693</loc>
    <lastmod>2026-10-02T13:21:32.693Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VSNT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Versant Signs Multi-Year Renewal Distribution Deal With Verizon For Its Portfolio Of Products</image:title>
      <image:caption>Versant (NASDAQ: VSNT) has announced a multi-year renewal of its distribution agreement with Verizon, ensuring that its portfolio of brands, including USA Network, CNBC, and Golf Channel, remains available to Verizon customers. This agreement marks the completion of Versant&#39;s renewal of all distribution partnerships set to expire in 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ARXS:1790947203162</loc>
    <lastmod>2026-10-02T13:20:03.162Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ARXS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Upgrades Arxis to Outperform, Raises Price Target to $60</image:title>
      <image:caption>RBC Capital analyst Ken Herbert has upgraded Arxis (NASDAQ: ARXS) from Sector Perform to Outperform. The price target for the stock has been raised from $50 to $60.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VYLR:1790947108920</loc>
    <lastmod>2026-10-02T13:18:28.920Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VYLR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Initiates Coverage On Vylor with Outperform Rating, Announces Price Target of $85</image:title>
      <image:caption>RBC Capital analyst Arun Viswanathan has initiated coverage on Vylor (NYSE: VYLR) with an Outperform rating. The firm has set a price target of $85 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RIVN:1790947107468</loc>
    <lastmod>2026-10-02T13:18:27.468Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RIVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Rivian Automotive shares are trading higher after the company reported Q3 production and delivery results.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ONTO:1790947007199</loc>
    <lastmod>2026-10-02T13:16:47.199Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ONTO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Onto Innovation shares are trading higher after RBC Capital initiated coverage on the stock with an Outperform rating and announced a $400 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ACN:1790946990372</loc>
    <lastmod>2026-10-02T13:16:30.372Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Evercore ISI Group Maintains Outperform on Accenture, Raises Price Target to $250</image:title>
      <image:caption>Evercore ISI Group analyst David Togut has maintained an &#39;Outperform&#39; rating on Accenture (NYSE: ACN) and raised the price target from $180 to $250. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ONTO:1790946944304</loc>
    <lastmod>2026-10-02T13:15:44.304Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ONTO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Initiates Coverage On Onto Innovation with Outperform Rating, Announces Price Target of $400</image:title>
      <image:caption>RBC Capital analyst Srini Pajjuri has initiated coverage on Onto Innovation (NYSE: ONTO) with an Outperform rating. The firm has set a price target of $400 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/WDC:1790946933175</loc>
    <lastmod>2026-10-02T13:15:33.175Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/Irvine--California--Usa---July-9--2022-W.jpg?width=250&amp;height=187</image:loc>
      <image:title>Toshiba Wants to Double HDD Supply — Western Digital, Seagate Investors Don’t Like It</image:title>
      <image:caption>Toshiba plans to double its hard disk drive (HDD) supply by fiscal 2027, investing approximately 60 billion yen ($380 million) to expand facilities in the Philippines, which has led to a decline in stock prices for Western Digital and Seagate Technology. Western Digital&#39;s stock fell 7.95% and Seagate&#39;s by 11.22% amid concerns that increased supply could pressure pricing in the HDD market. Despite Toshiba&#39;s expansion, demand for HDDs remains strong due to the AI boom, with S&amp;P Global projecting Western Digital&#39;s revenue growth of 44% in fiscal 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ALGM:1790946839613</loc>
    <lastmod>2026-10-02T13:13:59.613Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ALGM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Initiates Coverage On Allegro Microsystems with Outperform Rating, Announces Price Target of $50</image:title>
      <image:caption>RBC Capital analyst Srini Pajjuir has initiated coverage on Allegro Microsystems (NASDAQ: ALGM) with an Outperform rating. The firm has set a price target of $50 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CYCU:1790946712410</loc>
    <lastmod>2026-10-02T13:11:52.410Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CYCU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cycurion shares are trading higher after the company announced it regained Nasdaq compliance.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ACN:1790946693857</loc>
    <lastmod>2026-10-02T13:11:33.857Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/Accenture.jpg?width=250&amp;height=187</image:loc>
      <image:title>Accenture Analysts Boost Their Forecasts After Strong Q4 Results</image:title>
      <image:caption>Accenture plc reported strong fiscal Q4 2026 results, with earnings of $3.29 per share, surpassing the analyst estimate of $3.18, and revenue of $18.70 billion, exceeding the consensus estimate of $18.03 billion. For fiscal 2027, the company projects adjusted earnings of $14.39 to $14.81 per share and revenue between $76.43 billion and $78.65 billion, both above analyst expectations. Following the earnings announcement, analysts adjusted their price targets, with Morgan Stanley raising it to $195, Susquehanna to $210, and Argus Research to $260. Accenture shares fell 0.5% to $211.22 in pre-market trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SYNA:1790946539705</loc>
    <lastmod>2026-10-02T13:08:59.705Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/Stock-chartbenzingaai2023-stock-market-c.png?width=250&amp;height=187</image:loc>
      <image:title>Synaptics Stock Rises After onsemi Revises Deal to $123 Per Share</image:title>
      <image:caption>Synaptics Incorporated (NASDAQ: SYNA) is set to be acquired by onsemi for $123 per share, valuing the transaction at approximately $5.7 billion, down from $7 billion in a prior agreement. The all-cash deal is expected to be immediately accretive to onsemi&#39;s non-GAAP earnings per share and has been approved by the U.S. Federal Trade Commission, with closing anticipated by mid-2027 pending shareholder approval. Following the announcement, Synaptics shares rose 14.53% to $121.57.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TAYD:1790946529949</loc>
    <lastmod>2026-10-02T13:08:49.949Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TAYD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Taylor Devices shares are trading lower after the company reported worse-than-expected Q1 EPS results.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NVDA:1790946513941</loc>
    <lastmod>2026-10-02T13:08:33.941Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nvidia Rolls Out DGX Spark 64GB Configuration From Major Partners This Month; DGX Spark 64GB Supports Up To 100B Parameter Models On Device; DGX Spark 64GB Available Oct. 23 From $4,999 Through Major Partners</image:title>
      <image:caption>Nvidia has announced the rollout of its DGX Spark 64GB configuration, which supports models with up to 100 billion parameters. The DGX Spark 64GB will be available starting October 23, 2023, with a starting price of $4,999 through major partners. This new offering is expected to enhance Nvidia&#39;s position in the AI market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SCNX:1790946496943</loc>
    <lastmod>2026-10-02T13:08:16.943Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SCNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Scienture Holdings shares are trading higher after the company announced that Arbli Oral Suspension, 10 mg/mL has been added to the formulary of three leading U.S. pediatric academic medical centers and hospitals specializing in the treatment of children with complex and chronic medical conditions.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SGMT:1790946419044</loc>
    <lastmod>2026-10-02T13:06:59.044Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SGMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Guggenheim Maintains Buy on Sagimet Biosciences, Raises Price Target to $26</image:title>
      <image:caption>Guggenheim analyst Seamus Fernandez has maintained a Buy rating on Sagimet Biosciences (NASDAQ: SGMT) and has raised the price target from $25 to $26.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MBX:1790946339631</loc>
    <lastmod>2026-10-02T13:05:39.631Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MBX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Guggenheim Maintains Buy on MBX Biosciences, Raises Price Target to $150</image:title>
      <image:caption>Guggenheim analyst Seamus Fernandez has maintained a Buy rating on MBX Biosciences (NASDAQ: MBX) and raised the price target from $88 to $150. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CUPR:1790946308916</loc>
    <lastmod>2026-10-02T13:05:08.916Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CUPR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cuprina Holdings To Acquire East Coast Podiatry And Orchard Clinic For ~$3.1M</image:title>
      <image:caption>Cuprina Holdings has announced its acquisition of East Coast Podiatry and Orchard Clinic for approximately S$4.0 million (about US$3.1 million). The Target Group generated unaudited revenue of approximately S$9.1 million and normalized EBITDA of approximately S$1.2 million for FY2025. The purchase will be financed with S$3.0 million in cash and S$1.0 million in Class A ordinary shares, which will be subject to a lock-up period. The transaction is expected to close by November 1, 2026, pending customary conditions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NKE:1790946285091</loc>
    <lastmod>2026-10-02T13:04:45.091Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/02/Analysts-Adjust-Progressive-Targets.jpg?width=250&amp;height=187</image:loc>
      <image:title>These Analysts Cut Their Forecasts On Nike Following Q1 Results</image:title>
      <image:caption>Nike Inc. reported first-quarter revenue of $11.21 billion, missing analyst estimates of $11.33 billion, while adjusted earnings per share were 48 cents, exceeding expectations of 44 cents. The company anticipates a revenue decline in the high-single digits for fiscal 2027 and adjusted earnings guidance of $1.15 to $1.35 per share, below the estimate of $1.69. Following the earnings announcement, Nike shares fell 8.1% to $32.30, prompting analysts to adjust their price targets, with BTIG lowering it from $55 to $50 and B of A Securities from $30 to $24.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GLD:1790946214447</loc>
    <lastmod>2026-10-02T13:03:34.447Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>September Jobs Report Misses: US Economy Adds 29,000 Jobs</image:title>
      <image:caption>In September, the U.S. economy added only 29,000 nonfarm payrolls, significantly below the expected 90,000, with the unemployment rate rising to 4.2%. Wage growth also fell short of forecasts, with average hourly earnings increasing by just 0.1% month-over-month. Following the report, the likelihood of a 25-basis-point rate hike by the Federal Reserve dropped from 23% to 13%, leading to a rally in stocks, with the S&amp;P 500 up 0.41% in premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AGEN:1790946195056</loc>
    <lastmod>2026-10-02T13:03:15.056Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AGEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Agenus To Present Research On Botensilimab, Fc-Enhanced Multifunctional Anti-CTLA-4 Antibody, In Combination With Balstilimab, Anti-PD-1 Antibody, At SITC 2026</image:title>
      <image:caption>Agenus Inc. (NASDAQ: AGEN) announced that two research posters on botensilimab (BOT), an anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, have been accepted for presentation at the SITC 2026 Annual Meeting scheduled for November 4-8, 2026, in Phoenix, Arizona. One poster will focus on long-term survivors of refractory microsatellite-stable metastatic colorectal cancer treated with BOT+BAL, while the other will discuss preclinical research involving BOT+BAL and MiNK Therapeutics’ agenT-797 in colorectal cancer liver metastases.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/IART:1790946174791</loc>
    <lastmod>2026-10-02T13:02:54.791Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IART/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Integra LifeSciences shares are trading lower after the company announced it anticipates that flooding will disrupt Q3 revenue. The company narrowed its FY26 adjusted EPS guidance and cut its FY26 revenue.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ORCL:1790946151836</loc>
    <lastmod>2026-10-02T13:02:31.836Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ORCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oracle Announces Commitment To Implement Actions To Save ~$300M In Fuels Costs For Wisconsin Clients</image:title>
      <image:caption>Oracle has committed to subscribe to a portion of the electricity generation from the Point Beach Nuclear Plant, which is projected to save Wisconsin utility customers around $300 million in fuel costs. This initiative aims to alleviate the rising costs associated with the plant, reduce household electricity bills, and ensure reliable power for the Wisconsin grid.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ORCL:1790945999132</loc>
    <lastmod>2026-10-02T12:59:59.132Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ORCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citizens Reiterates Market Outperform on Oracle, Maintains $285 Price Target</image:title>
      <image:caption>Citizens analyst Patrick Walravens has reiterated a Market Outperform rating on Oracle (NYSE: ORCL) and has maintained a price target of $285 for the stock. This indicates a positive outlook for Oracle&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
</urlset>